ADCC-Mediated CD56dim NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection

Hepatitis B virus (HBV) affects up to 400 million people worldwide and accounts for approximately one million deaths per year from liver pathologies. Current treatment regimens are effective in suppressing viremia but usually have to be taken indefinitely, warranting research into new therapeutic ap...

Full description

Bibliographic Details
Main Authors: Wen-Han Yu, Cormac Cosgrove, Christoph T. Berger, Patrick C. Cheney, Marina Krykbaeva, Arthur Y. Kim, Lia Lewis-Ximenez, Georg M. Lauer, Galit Alter
Format: Article
Language:English
Published: Case Western Reserve University 2018-02-01
Series:Pathogens and Immunity
Subjects:
Online Access:http://paijournal.com/index.php/paijournal/article/view/228
_version_ 1818515722746200064
author Wen-Han Yu
Cormac Cosgrove
Christoph T. Berger
Patrick C. Cheney
Marina Krykbaeva
Arthur Y. Kim
Lia Lewis-Ximenez
Georg M. Lauer
Galit Alter
author_facet Wen-Han Yu
Cormac Cosgrove
Christoph T. Berger
Patrick C. Cheney
Marina Krykbaeva
Arthur Y. Kim
Lia Lewis-Ximenez
Georg M. Lauer
Galit Alter
author_sort Wen-Han Yu
collection DOAJ
description Hepatitis B virus (HBV) affects up to 400 million people worldwide and accounts for approximately one million deaths per year from liver pathologies. Current treatment regimens are effective in suppressing viremia but usually have to be taken indefinitely, warranting research into new therapeutic approaches. Acute HBV infection in adults almost universally results in resolution of viremia, with the exception of immunocompromised persons, suggesting that the immune response can functionally cure or even eradicate HBV infection. Because immunophenotypic and functional studies have implicated a role for Natural Killer (NK) cells in HBV clearance during acute infection, we hypothesized that a distinct NK-cell profile exists in acute HBV infection that could provide information for the mechanism of HBV clearance. Using multivariate flow cytometry, we evaluated the expression of key activating and inhibitory receptors on NK cells, and their ability to respond to classic target cell lines. Multivariate analysis revealed selective perturbation of the CD56 dim NK-cell subset during acute infection, displaying low levels of NKp46+, NKp30+, CD160+ and CD161+ cells. Intriguingly, the CD56 dim NK-cell profile predicted time to HBV surface antigen (HBsAg) clearance from the blood, and distinct NK-cell profiles predicted early (NKp30, CD94, CD161) and late clearance (KIR3DL1, CD158a, perforin, NKp46). Finally, functional analysis demonstrated that early and late clearance tracked with elevated degranulation (CD107a) or IFNγ production, respectively, in response to ADCC-mediated activation. In conclusion, the cytolytic CD56dim NK-cell subset is selectively activated in acute HBV infection and displays distinct phenotypic and functional profiles associated with efficient and early control of HBV, implicating antibody-mediated cytolytic NK-cell responses in the early control and functional cure of HBV infection.
first_indexed 2024-12-11T00:32:37Z
format Article
id doaj.art-957276730eca4b65ac10d710bfc6fa05
institution Directory Open Access Journal
issn 2469-2964
language English
last_indexed 2024-12-11T00:32:37Z
publishDate 2018-02-01
publisher Case Western Reserve University
record_format Article
series Pathogens and Immunity
spelling doaj.art-957276730eca4b65ac10d710bfc6fa052022-12-22T01:27:18ZengCase Western Reserve UniversityPathogens and Immunity2469-29642018-02-013121810.20411/pai.v3i1.22874ADCC-Mediated CD56dim NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV InfectionWen-Han Yu0Cormac Cosgrove1Christoph T. Berger2Patrick C. Cheney3Marina Krykbaeva4Arthur Y. Kim5Lia Lewis-Ximenez6Georg M. Lauer7Galit Alter8Ragon InstituteThe Ragon Institute of MGH, MIT and Harvard, Cambridge, MassachusettsDepartment of Biomedicine, University Hospital Basel, SwitzerlandThe Ragon Institute of MGH, MIT and Harvard, Cambridge, MassachusettsThe Ragon Institute of MGH, MIT and Harvard, Cambridge, MassachusettsMassachusetts General Hospital, Boston, MassachusettsInstituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, BrazilMassachusetts General Hospital, Boston, MassachusettsThe Ragon Institute of MGH, MIT and Harvard, Cambridge, MassachusettsHepatitis B virus (HBV) affects up to 400 million people worldwide and accounts for approximately one million deaths per year from liver pathologies. Current treatment regimens are effective in suppressing viremia but usually have to be taken indefinitely, warranting research into new therapeutic approaches. Acute HBV infection in adults almost universally results in resolution of viremia, with the exception of immunocompromised persons, suggesting that the immune response can functionally cure or even eradicate HBV infection. Because immunophenotypic and functional studies have implicated a role for Natural Killer (NK) cells in HBV clearance during acute infection, we hypothesized that a distinct NK-cell profile exists in acute HBV infection that could provide information for the mechanism of HBV clearance. Using multivariate flow cytometry, we evaluated the expression of key activating and inhibitory receptors on NK cells, and their ability to respond to classic target cell lines. Multivariate analysis revealed selective perturbation of the CD56 dim NK-cell subset during acute infection, displaying low levels of NKp46+, NKp30+, CD160+ and CD161+ cells. Intriguingly, the CD56 dim NK-cell profile predicted time to HBV surface antigen (HBsAg) clearance from the blood, and distinct NK-cell profiles predicted early (NKp30, CD94, CD161) and late clearance (KIR3DL1, CD158a, perforin, NKp46). Finally, functional analysis demonstrated that early and late clearance tracked with elevated degranulation (CD107a) or IFNγ production, respectively, in response to ADCC-mediated activation. In conclusion, the cytolytic CD56dim NK-cell subset is selectively activated in acute HBV infection and displays distinct phenotypic and functional profiles associated with efficient and early control of HBV, implicating antibody-mediated cytolytic NK-cell responses in the early control and functional cure of HBV infection.http://paijournal.com/index.php/paijournal/article/view/228HBVNK cellsHBsAgADCC
spellingShingle Wen-Han Yu
Cormac Cosgrove
Christoph T. Berger
Patrick C. Cheney
Marina Krykbaeva
Arthur Y. Kim
Lia Lewis-Ximenez
Georg M. Lauer
Galit Alter
ADCC-Mediated CD56dim NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection
Pathogens and Immunity
HBV
NK cells
HBsAg
ADCC
title ADCC-Mediated CD56dim NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection
title_full ADCC-Mediated CD56dim NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection
title_fullStr ADCC-Mediated CD56dim NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection
title_full_unstemmed ADCC-Mediated CD56dim NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection
title_short ADCC-Mediated CD56dim NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection
title_sort adcc mediated cd56dim nk cell responses are associated with early hbsag clearance in acute hbv infection
topic HBV
NK cells
HBsAg
ADCC
url http://paijournal.com/index.php/paijournal/article/view/228
work_keys_str_mv AT wenhanyu adccmediatedcd56dimnkcellresponsesareassociatedwithearlyhbsagclearanceinacutehbvinfection
AT cormaccosgrove adccmediatedcd56dimnkcellresponsesareassociatedwithearlyhbsagclearanceinacutehbvinfection
AT christophtberger adccmediatedcd56dimnkcellresponsesareassociatedwithearlyhbsagclearanceinacutehbvinfection
AT patrickccheney adccmediatedcd56dimnkcellresponsesareassociatedwithearlyhbsagclearanceinacutehbvinfection
AT marinakrykbaeva adccmediatedcd56dimnkcellresponsesareassociatedwithearlyhbsagclearanceinacutehbvinfection
AT arthurykim adccmediatedcd56dimnkcellresponsesareassociatedwithearlyhbsagclearanceinacutehbvinfection
AT lialewisximenez adccmediatedcd56dimnkcellresponsesareassociatedwithearlyhbsagclearanceinacutehbvinfection
AT georgmlauer adccmediatedcd56dimnkcellresponsesareassociatedwithearlyhbsagclearanceinacutehbvinfection
AT galitalter adccmediatedcd56dimnkcellresponsesareassociatedwithearlyhbsagclearanceinacutehbvinfection